Operating Profit Changement Date
Adcock Ingram Holdings ZAR 541.49M 52.55M 2023-06
Deva Holding AS TRY 964.87M 240.32M 2023-09
Ecofibre AUD -3356000 20.27M 2023-06
Eli Lilly USD 2.39B 1.94B 2023-12
Knight Therapeutics CAD 2.29M 1.5M 2023-09
Laboratorios Farma EUR 85.28M 66.78M 2023-06
Malin Corporation EUR -2200000 800K 2023-06
Medical Developments International AUD -11427000 4.13M 2023-06
Nektar Therapeutics USD -44864000 5.74M 2023-09
Neuren Pharmaceuticals AUD 48.83M 41.89M 2023-06
Organigram Holdings CAD -219637000 208.87M 2023-03
Ovoca Bio EUR -5647000 3.45M 2022-06
Pacira USD 33.17M 15.45M 2023-12
Perrigo USD 62.1M 5.3M 2023-09
Pharma Mar EUR -184000 4.23M 2023-09
Probiotec AUD 8.03M 492.24K 2023-06
Qiagen NV USD 97.18M 8.25M 2023-09
Sartorius EUR 80M 45.4M 2023-09
Sino Biopharmaceutical CNY 3.75B 797.83M 2023-06
Supernus Pharmaceuticals USD -996000 9.13M 2023-12
Zz Pientze Pharmaceu 1.04B 113.61M 2023-09



Xeris Pharmaceuticals Le Bénéfice D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2024.